Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment

Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment

Background: Patient preferences for treatment outcomes are important to guide decision-making in clinical practice, but little is known about the preferences of patients with metastatic hormone-sensitive prostate cancer (mHSPC). Objective: To evaluate patient preferences regarding the attributed ben...

Full description

Bibliographic Details
Main Authors:	Dominik Menges, Michela C. Piatti, Aurelius Omlin, Richard Cathomas, Daniel Benamran, Stefanie Fischer, Christophe Iselin, Marc Küng, Anja Lorch, Lukas Prause, Christian Rothermundt, Alix O'Meara Stern, Deborah Zihler, Max Lippuner, Julia Braun, Thomas Cerny, Milo A. Puhan
Format:	Article
Language:	English
Published:	Elsevier 2023-05-01
Series:	European Urology Open Science
Subjects:	Adverse effects Benefit Benefit-harm assessment Discrete choice experiment Harm Metastasis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168323001258

Similar Items

Fasting: Benefits and probable health harmfulness from the Islamic perspective
by: Mahdi Ebrahimi, et al.
Published: (2015-06-01)

Fasting: Benefits and probable health harmfulness from the Islamic perspective
by: Mahdi Ebrahimi, et al.
Published: (2015-06-01)

Patient Preference Studies for Advanced Prostate Cancer Treatment Along the Medical Product Life Cycle: Systematic Literature Review
by: Menges D, et al.
Published: (2022-06-01)

Editorial: Therapeutic approaches in youth psychiatry – The art of balancing between ‘do not harm’ and ‘best attainable care’
by: Soumitra Das, et al.
Published: (2023-02-01)

Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study
by: Henock G. Yebyo, et al.
Published: (2020-09-01)

Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts
by: Henock G. Yebyo, et al.
Published: (2018-05-01)

Benefits and harms of screening for hepatocellular carcinoma in high-risk populations: systematic review and meta-analysis
by: Jichun Yang, et al.
Published: (2023-09-01)

Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study
by: Erik E. L. Jansen, et al.
Published: (2022-11-01)

A Critical Perspective on the Supplementation of <i>Akkermansia muciniphila</i>: Benefits and Harms
by: Vito Chiantera, et al.
Published: (2023-05-01)

Risk-based lung cancer screening in heavy smokers: a benefit–harm and cost-effectiveness modeling study
by: Yin Liu, et al.
Published: (2024-02-01)

Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease
by: Hassan Saadati, et al.
Published: (2020-11-01)

Necessary, but Not Sufficient. The Benefit Concept in the Project Evaluation of Animal Research in the Context of Directive 2010/63/EU
by: Matthias Eggel, et al.
Published: (2018-02-01)

Reviewing the Review: A Pilot Study of the Ethical Review Process of Animal Research in Sweden
by: Svea Jörgensen, et al.
Published: (2021-03-01)

Benefit-to-harm ratio and cost-effectiveness of government-recommended gastric cancer screening in China: A modeling study
by: Shuxia Qin, et al.
Published: (2022-08-01)

Assessment of the Welfare of Experimental Cattle and Pigs Using the Animal Welfare Assessment Grid
by: Molly Ryan, et al.
Published: (2021-04-01)

Associations of the perceived benefits and harms of COVID-19 with confidence in coping with the pandemic and mental health symptoms: a population-based survey in Hong Kong
by: Ying Yao, et al.
Published: (2023-06-01)

Estimating and visualising the trade-off between benefits and harms on multiple clinical outcomes in network meta-analysis
by: Virginia Chiocchia, et al.
Published: (2023-11-01)

“Drugs to avoid” to improve quality use of medicines: how is Australia faring?
by: Agnes Vitry, et al.
Published: (2021-12-01)

Discoveries and application of prostate-specific antigen, and some proposals to optimize prostate cancer screening
by: Tokudome S, et al.
Published: (2016-05-01)

Treatment Benefit and Treatment Harm Rates with Nonignorable Missing Covariate, Endpoint, or Treatment
by: Yi He, et al.
Published: (2023-10-01)

The five self-harm behavior groupings measure: empirical and thematic data from a novel comprehensive self-harm assessment
by: Sophie I. Liljedahl, et al.
Published: (2023-05-01)

Harm minimisation for the management of self-harm: a mixed-methods analysis of electronic health records in secondary mental healthcare
by: Charlotte Cliffe, et al.
Published: (2021-07-01)

Substantial increase in perceived benefits over harms of COVID-19 outbreak but persistent socioeconomic disparities: Comparison of two cross-sectional surveys in Hong Kong from 2020 to 2021
by: Hiu Tin Leung, et al.
Published: (2022-11-01)

Measuring the impact of zero-cases studies in evidence synthesis practice using the harms index and benefits index (Hi-Bi)
by: Chang Xu, et al.
Published: (2023-03-01)

Update on depression and deliberate self-harm
by: Shehan Williams, et al.
Published: (2010-12-01)

PANSAID—PAracetamol and NSAID in combination: detailed statistical analysis plan for a randomised, blinded, parallel, four-group multicentre clinical trial
by: Kasper Højgaard Thybo, et al.
Published: (2017-10-01)

Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios
by: Abraham M. Getaneh, et al.
Published: (2020-10-01)

Gambling harm prevention and harm reduction in online environments: a call for action
by: Virve Marionneau, et al.
Published: (2023-07-01)

Harm reduction behaviours and harm experiences of people who use 3,4-methylenedioxymethamphetamine (MDMA) in Aotearoa New Zealand
by: Jai Whelan, et al.
Published: (2024-03-01)

LEGISLATIVE FORMATION OF THE BASES OF HARM INDEMNIFICATION IILEGALLY IMPOSED BY THE STATE DURING CRIMINAL PROSECUTION IN THE RUSSIAN EMPIRE PERIOD
by: B. A. Polyakov
Published: (2013-03-01)

Self-harm Behaviors among University Students
by: kiana Sabet Dizkuhi, et al.
Published: (2021-07-01)

Navigating Uncertainties: How to Assess Welfare and Harm in Genetically Altered Animals Responsibly—A Practical Guideline
by: Anne Zintzsch, et al.
Published: (2020-05-01)

First, do no harm: The patient's experience of avoidable suffering as harm
by: Ashley Bauer
Published: (2018-11-01)

Attitudes toward pre-symptomatic screening for Alzheimer’s dementia in five European countries: a comparison of family members of people with Alzheimer’s dementia versus non-family members
by: Ioanna A. Angelidou, et al.
Published: (2023-12-01)

The Role of Unemployment, Financial Hardship, and Economic Recession on Suicidal Behaviors and Interventions to Mitigate Their Impact: A Review
by: Sharna Mathieu, et al.
Published: (2022-07-01)

The inter-connections between self-harm and aggressive behaviours: A general network analysis study of dual harm
by: Matina Shafti, et al.
Published: (2022-07-01)

The Co-occurrence of Self-Harm and Aggression: A Cognitive-Emotional Model of Dual-Harm
by: Matina Shafti, et al.
Published: (2021-02-01)

Enhanced self-harm presentation reporting using additional ICD-10 codes and free text in NSW emergency departments
by: Grant E Sara, et al.
Published: (2023-09-01)

First German-speaking harm reduction conference in Vienna
by: Larissa Steimle, et al.
Published: (2024-01-01)

Deliberate self-harm seen in a government licensed private psychiatric hospital and institute
by: Vaithiyam Devendran Krishnaram, et al.
Published: (2016-01-01)